MedPath

Phase I study for dose escalation in limited small cell lung cancer

Phase 1
Conditions
imited small cell lung cancer
Registration Number
JPRN-UMIN000005911
Lead Sponsor
Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Uncontrollable DM 2) Collagen disease 3) Concurrent cancer with activity 4) Pregnant 5) Elonging treatment time

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acute toxicity G3 or more
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath